SAN FRANCISCO, Dec. 26, 2024 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for chronic...
Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B )
Also on site :
- Today’s NYT ‘Strands’ Hints, Spangram and Answers for Saturday, June 7
- Pop Icon Looks Unrecognizable After Ditching '80s Glam in Makeup-Free Selfie
- Taylor Swift and Travis Kelce Dance At Surprising Backyard Wedding Appearance